单倍型造血干细胞移植治疗26例复发难治侵袭性非霍奇金淋巴瘤疗效和安全性研究

OBJECTIVE: To explore the efficacy and safety of haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) for refractory, relapsed or highly aggressive non-Hodgkin lymphoma (NHL) patients. METHODS: A total of 26 patients with refractory, relapsed or highly aggressive NHL who received Hapl...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348539/
https://www.ncbi.nlm.nih.gov/pubmed/27587245
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348539/
https://www.ncbi.nlm.nih.gov/pubmed/27587245
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.005

Ejemplares similares